Sestrin2 in diabetes and diabetic complications

被引:0
|
作者
Zhang, Xiaodan [1 ]
Luo, Zirui [2 ]
Li, Jiahong [2 ]
Lin, Yaxuan [2 ]
Li, Yu [1 ]
Li, Wangen [1 ]
机构
[1] Guangzhou Med Univ, Dept Endocrinol, Affiliated Hosp 2, Guangzhou 510260, Guangdong, Peoples R China
[2] Guangzhou Med Univ, Clin Med Sch 2, Guangzhou, Peoples R China
来源
基金
中国国家自然科学基金;
关键词
diabetes; diabetic complications; Sestrin2; oxidative stress; mitochondrial function; POTENTIAL THERAPEUTIC TARGET; UNFOLDED PROTEIN RESPONSE; AGE-RELATED INTOLERANCE; ER STRESS; OXIDATIVE STRESS; SIGNALING PATHWAY; HIGH-GLUCOSE; CELL-DEATH; CARDIAC DYSFUNCTION; INSULIN-SENSITIVITY;
D O I
10.3389/fendo.2023.1274686
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes is a global health problem which is accompanied with multi-systemic complications. It is of great significance to elucidate the pathogenesis and to identify novel therapies of diabetes and diabetic complications. Sestrin2, a stress-inducible protein, is primarily involved in cellular responses to various stresses. It plays critical roles in regulating a series of cellular events, such as oxidative stress, mitochondrial function and endoplasmic reticulum stress. Researches investigating the correlations between Sestrin2, diabetes and diabetic complications are increasing in recent years. This review incorporates recent findings, demonstrates the diverse functions and regulating mechanisms of Sestrin2, and discusses the potential roles of Sestrin2 in the pathogenesis of diabetes and diabetic complications, hoping to highlight a promising therapeutic direction.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Sestrin2 in atherosclerosis
    Tian, Zhen
    Yan, Bin-Jie
    Luo, Wen
    Gui, Dan-Dan
    Zhou, Kun
    Tian, Kai-Jiang
    Ma, Yun
    Zhou, Zhi-Xiang
    Jiang, Zhi-Sheng
    CLINICA CHIMICA ACTA, 2021, 523 : 325 - 329
  • [2] Sestrin2 ameliorates diabetic retinopathy by regulating autophagy and ferroptosis
    Xiaoting Xi
    Qianbo Chen
    Jia Ma
    Xuewei Wang
    Junyan Zhang
    Yan Li
    Journal of Molecular Histology, 2024, 55 : 169 - 184
  • [3] Sestrin2 ameliorates diabetic retinopathy by regulating autophagy and ferroptosis
    Xi, Xiaoting
    Chen, Qianbo
    Ma, Jia
    Wang, Xuewei
    Zhang, Junyan
    Li, Yan
    JOURNAL OF MOLECULAR HISTOLOGY, 2024, 55 (02) : 169 - 184
  • [4] The impact of sestrin2 on reactive oxygen species in diabetic retinopathy
    Yang, Xueli
    Wu, Xiaoli
    CELL BIOCHEMISTRY AND FUNCTION, 2024, 42 (04)
  • [5] Correction: Sestrin2 ameliorates diabetic retinopathy by regulating autophagy and ferroptosis
    Xiaoting Xi
    Qianbo Chen
    Jia Ma
    Xuewei Wang
    Junyan Zhang
    Yan Li
    Journal of Molecular Histology, 2024, 55 : 185 - 185
  • [6] Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients
    En-Wen Mao
    Xue-Bing Cheng
    Wen-Chao Li
    Cheng-Xia Kan
    Na Huang
    Hong-Sheng Wang
    Ning-Ning Hou
    Xiao-Dong Sun
    World Journal of Clinical Cases, 2021, (36) : 11156 - 11164
  • [7] Maintenance of Metabolic Homeostasis by Sestrin2 and Sestrin3
    Lee, Jun Hee
    Budanov, Andrei V.
    Talukdar, Saswata
    Park, Eek Joong
    Park, Hae Li
    Park, Hwan-Woo
    Bandyopadhyay, Gautam
    Li, Ning
    Aghajan, Mariam
    Jang, Insook
    Wolfe, Amber M.
    Perkins, Guy A.
    Ellisman, Mark H.
    Bier, Ethan
    Scadeng, Miriam
    Foretz, Marc
    Viollet, Benoit
    Olefsky, Jerrold
    Karin, Michael
    CELL METABOLISM, 2012, 16 (03) : 311 - 321
  • [8] Sestrin2 in cancer: a foe or a friend?
    Moein Ala
    Biomarker Research, 10
  • [9] Association between serum Sestrin2 level and diabetic peripheral neuropathy in type 2 diabetic patients
    Mao, En-Wen
    Cheng, Xue-Bing
    Li, Wen-Chao
    Kan, Cheng-Xia
    Huang, Na
    Wang, Hong-Sheng
    Hou, Ning-Ning
    Sun, Xiao-Dong
    WORLD JOURNAL OF CLINICAL CASES, 2021, 9 (36) : 11156 - 11164
  • [10] Sestrin2 as a Potential Target in Hypertension
    Didik, Steven
    Wang, Hao
    James, Adewale Segun
    Slotabec, Lily
    Li, Ji
    DIAGNOSTICS, 2023, 13 (14)